WEREWOLF THERAPEUTICS, INC. Depreciation
WEREWOLF THERAPEUTICS, INC. (HOWL) reported Depreciation of $2.85 million for the 6-month period ending 2026-06-30, per its S-4 filed 2026-09-22.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-09-22
- WEREWOLF THERAPEUTICS, INC. depreciation for the quarter ending 2026-06-30 was $2.45M, a 503.94% increase year-over-year.
- WEREWOLF THERAPEUTICS, INC. depreciation for the quarter ending 2026-03-31 was $398.00K, a 6.57% decline year-over-year.
- WEREWOLF THERAPEUTICS, INC. depreciation for the quarter ending 2025-12-31 was $400.00K, a 9.50% decline year-over-year.
- WEREWOLF THERAPEUTICS, INC. depreciation for the quarter ending 2025-09-30 was $402.00K, a 11.45% decline year-over-year.
- WEREWOLF THERAPEUTICS, INC. depreciation for fiscal 2023 was $1.76M, a 59.78% increase from fiscal 2022.
- WEREWOLF THERAPEUTICS, INC. depreciation for fiscal 2022 was $1.10M, a 411.11% increase from fiscal 2021.
- WEREWOLF THERAPEUTICS, INC. depreciation for fiscal 2021 was $216.00K, a 44.00% increase from fiscal 2020.
- WEREWOLF THERAPEUTICS, INC. depreciation for fiscal 2020 was $150.00K.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.45M derived: S-4 6 month − 10-Q 3 month · filed 2026-09-22 | $2.85M S-4 · filed 2026-09-22 | $3.25M derived: sum of 3 quarters · filed 2026-09-22 | $3.65M derived: sum of 4 quarters · filed 2026-09-22 |
| 2026-03-31 | $398.00K 10-Q · filed 2026-05-07 | $798.00K derived: sum of 2 quarters · filed 2026-09-22 | $1.20M derived: sum of 3 quarters · filed 2026-09-22 | $1.61M derived: sum of 4 quarters · filed 2026-09-22 |
| 2025-12-31 | $400.00K derived: S-4 12 month − 10-Q 9 month · filed 2026-09-22 | $802.00K derived: sum of 2 quarters · filed 2026-09-22 | $1.21M derived: sum of 3 quarters · filed 2026-09-22 | $1.63M S-4 · filed 2026-09-22 |
| 2025-09-30 | $402.00K derived: 10-Q 9 month − S-4 6 month · filed 2025-11-04 | $808.00K derived: sum of 2 quarters · filed 2026-09-22 | $1.23M 10-Q · filed 2025-11-04 | $1.68M derived: sum of 4 quarters · filed 2026-09-22 |
| 2025-06-30 | $406.00K derived: S-4 6 month − 10-Q 3 month · filed 2026-09-22 | $832.00K S-4 · filed 2026-09-22 | $1.27M derived: sum of 3 quarters · filed 2026-09-22 | $1.73M derived: sum of 4 quarters · filed 2026-09-22 |
| 2025-03-31 | $426.00K 10-Q · filed 2026-05-07 | $868.00K derived: sum of 2 quarters · filed 2026-09-22 | $1.32M derived: sum of 3 quarters · filed 2026-09-22 | $1.78M derived: sum of 4 quarters · filed 2026-09-22 |
| 2024-12-31 | $442.00K derived: S-4 12 month − 10-Q 9 month · filed 2026-09-22 | $896.00K derived: sum of 2 quarters · filed 2026-09-22 | $1.35M derived: sum of 3 quarters · filed 2026-09-22 | $1.81M S-4 · filed 2026-09-22 |
| 2024-09-30 | $454.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $908.00K derived: sum of 2 quarters · filed 2025-11-04 | $1.37M 10-Q · filed 2025-11-04 | $1.83M derived: sum of 4 quarters · filed 2025-11-04 |
| 2024-06-30 | $454.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $918.00K 10-Q · filed 2025-08-14 | $1.38M derived: sum of 3 quarters · filed 2025-08-14 | $1.82M derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $464.00K 10-Q · filed 2025-05-08 | $924.00K derived: sum of 2 quarters · filed 2025-05-08 | $1.37M derived: sum of 3 quarters · filed 2025-05-08 | $1.80M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $460.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | $905.00K derived: sum of 2 quarters · filed 2025-03-11 | $1.34M derived: sum of 3 quarters · filed 2025-03-11 | $1.76M 10-K · filed 2025-03-11 |
| 2023-09-30 | $445.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $879.00K derived: sum of 2 quarters · filed 2024-11-07 | $1.30M 10-Q · filed 2024-11-07 | $1.72M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $434.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $859.00K 10-Q · filed 2024-08-08 | $1.28M derived: sum of 3 quarters · filed 2024-08-08 | $1.68M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $425.00K 10-Q · filed 2024-05-03 | $842.00K derived: sum of 2 quarters · filed 2024-05-03 | $1.25M derived: sum of 3 quarters · filed 2024-05-03 | $1.43M derived: sum of 4 quarters · filed 2024-05-03 |
| 2022-12-31 | $417.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | $821.00K derived: sum of 2 quarters · filed 2024-03-07 | $1.01M derived: sum of 3 quarters · filed 2024-03-07 | $1.10M 10-K · filed 2024-03-07 |
| 2022-09-30 | $404.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $589.00K derived: sum of 2 quarters · filed 2023-11-14 | $687.00K 10-Q · filed 2023-11-14 | $735.00K derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $185.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $283.00K 10-Q · filed 2023-08-10 | $331.00K derived: sum of 3 quarters · filed 2023-08-10 | $398.00K derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $98.00K 10-Q · filed 2023-05-11 | $146.00K derived: sum of 2 quarters · filed 2023-05-11 | $213.00K derived: sum of 3 quarters · filed 2023-05-11 | $275.00K derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $48.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $115.00K derived: sum of 2 quarters · filed 2023-03-23 | $177.00K derived: sum of 3 quarters · filed 2023-03-23 | $216.00K 10-K · filed 2023-03-23 |
| 2021-09-30 | $67.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $129.00K derived: sum of 2 quarters · filed 2022-11-10 | $168.00K 10-Q · filed 2022-11-10 | $212.00K derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $62.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $101.00K 10-Q · filed 2022-08-11 | $145.00K derived: sum of 3 quarters · filed 2022-08-11 | $186.00K derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $39.00K 10-Q · filed 2022-05-10 | $83.00K derived: sum of 2 quarters · filed 2022-05-10 | $124.00K derived: sum of 3 quarters · filed 2022-05-10 | $166.00K derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | $44.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | $85.00K derived: sum of 2 quarters · filed 2022-03-24 | $127.00K derived: sum of 3 quarters · filed 2022-03-24 | $150.00K 10-K · filed 2022-03-24 |
| 2020-09-30 | $41.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $83.00K derived: sum of 2 quarters · filed 2021-11-10 | $106.00K 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $42.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $65.00K 10-Q · filed 2021-08-12 | ||
| 2020-03-31 | $23.00K 10-Q · filed 2021-06-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |